These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7256961)

  • 1. [Estrogen receptor determination in malignant breast tumor tissue. How can false negative results be avoided?].
    Poulsen HS; Schultz HP; Hansen ES
    Ugeskr Laeger; 1981 Jan; 143(4):192-4. PubMed ID: 7256961
    [No Abstract]   [Full Text] [Related]  

  • 2. Fine needle biopsy in estrogen receptor determination in breast cancer.
    Lindgren A; Sällström J; Adami HO
    Eur J Cancer (1965); 1980; Suppl 1():67-9. PubMed ID: 7318872
    [No Abstract]   [Full Text] [Related]  

  • 3. False-negative assessment of oestrogen receptor on needle core biopsy of invasive carcinoma of the breast.
    Lee AH; Hodi Z; Ellis IO
    J Clin Pathol; 2008 Feb; 61(2):239-40. PubMed ID: 18223101
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor determination in human breast cancer.
    Parl FF
    Prog Clin Pathol; 1984; 9():155-72. PubMed ID: 6364221
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fluorescence microscopy determination of estrogen receptor activity in breast cancer].
    Frank K; Heine M; Remmele W
    Pathologe; 1980 Nov; 2(1):51-5. PubMed ID: 6258170
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of the receptor state in paraffin sections of breast neoplasms].
    Stagni F
    Pathologica; 1985; 77(1049):237-40. PubMed ID: 3913891
    [No Abstract]   [Full Text] [Related]  

  • 8. [Micro-analysis of hormone receptors in needle biopsies of human mammary lesions and tumors. Determination of estrogen receptors].
    Delarue JC; Mouriesse H; Contesso G; May-Levin F; Sancho-Garnier H
    Biomedicine; 1981 Dec; 34(3):153-60. PubMed ID: 7337801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone receptors in human breast cancer.
    Seckinger D
    J Fla Med Assoc; 1980 Feb; 67(2):198-202. PubMed ID: 7359111
    [No Abstract]   [Full Text] [Related]  

  • 10. The relevance of control histology in oestrogen receptor estimation.
    Steele RJ; Hawkins RA; Anderson TJ; Forrest AP
    Br J Cancer; 1987 Nov; 56(5):617-8. PubMed ID: 3322353
    [No Abstract]   [Full Text] [Related]  

  • 11. Early recurrence in oestrogen receptor negative breast carcinomas. A preliminary report.
    Hartveit F; Maartmann-Moe H; Støa KF; Tangen M; Thorsen T
    Acta Chir Scand; 1980; 146(2):93-5. PubMed ID: 7415751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of estrogen receptor data: recommendations for Iowa.
    Corder MP; Caughlan CR; Clark GR; Culp DA; Guthrie RT; Hass AC; Hoak JC; Jochimsen PR; Ketelaar RJ; Leafstedt SW; Maher LL; Wilmarth CB
    J Iowa Med Soc; 1980 Mar; 70(3):105-8. PubMed ID: 7365288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell collection from fine needle aspirates for estrogen receptor immunocytochemical assay.
    Earl M
    Acta Cytol; 1987; 31(3):377-8. PubMed ID: 3473875
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.
    Kurbel S
    Med Hypotheses; 2005; 64(6):1182-7. PubMed ID: 15823713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleomorphic adenoma of the breast with positive estrogen receptors.
    Segen JC; Foo M; Richer S
    N Y State J Med; 1986 May; 86(5):265-6. PubMed ID: 3012428
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrogen receptors in early breast cancer.
    Cooke T; George D; Schields R; Maynard PV; Griffiths K
    Eur J Cancer (1965); 1980; Suppl 1():53-7. PubMed ID: 7318869
    [No Abstract]   [Full Text] [Related]  

  • 17. Symposium on estrogen receptor determination with monoclonal antibodies. Monte Carlo, December 14, 1984.
    Cancer Res; 1986 Aug; 46(8 Suppl):4233s-4313s. PubMed ID: 3731089
    [No Abstract]   [Full Text] [Related]  

  • 18. Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes.
    Ross JS; Symmans WF; Pusztai L; Hortobagyi GN
    Clin Cancer Res; 2007 May; 13(10):2831-5. PubMed ID: 17504980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of estrogen receptors in breast cancer (author's transl)].
    Reiner G; Jakesz R; Kolb R; Bettelheim P; Bieglmayer C; Spona J
    Chir Forum Exp Klin Forsch; 1980; ():315-8. PubMed ID: 7389473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactive estrogen receptor in breast tumor and adjacent tissue: association with clinicopathological characteristics in Indian population.
    Kumar VL; Srivastava A; Singhal R; Kumar V
    J Surg Oncol; 2005 Mar; 89(4):251-5. PubMed ID: 15726618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.